SBI Securities’s Alzamend Neuro ALZN Stock Holding History

SBI Securities’s Portfolio ALZN Stock Details ALZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$38	Hold	22	–	–	﹤0.01%	3800
2026 Q2	$26	Hold	22	–	–	﹤0.01%	3789
2026 Q1	$23	Hold	22	–	–	﹤0.01%	3735
2025 Q4	$40	Hold	22	–	–	﹤0.01%	3624
2025 Q3	$52	Hold	22	–	–	﹤0.01%	3701
2025 Q2	$64	Buy	22 +20	+1,000%	+$99	﹤0.01%	3665
2025 Q1	$17	Hold	2	–	–	﹤0.01%	3882
2024 Q4	$21	Buy	+2	New	+$26	﹤0.01%	3821

Other funds holding ALZN

Kingsbury Capital Investment Advisors Wilmette, Illinois $106M AUM

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Harbor Investment Advisory Lutherville, Maryland $1.47B AUM 24.2% 1-Year Est. Return

SBI Securities's ALZN Position: Q3 2026 in Review

SBI Securities held its Alzamend Neuro (ALZN) position steady in Q3 2026 at 22 shares worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #3800.

SBI Securities first reported a position in ALZN in Q4 2024 and has held it in 8 quarters since. The position peaked at $64 in Q2 2025. 5 funds tracked by Wall St. Rank hold ALZN as of Q3 2026.

SBI Securities held 22 shares of Alzamend Neuro worth $38 as of Q3 2026.
SBI Securities left its Alzamend Neuro share count unchanged in Q3 2026.
Alzamend Neuro made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3800 holding.
SBI Securities first reported a position in Alzamend Neuro in Q4 2024 and has held it in 8 quarters since.
SBI Securities's Alzamend Neuro position peaked at $64 in Q2 2025.
5 funds tracked by Wall St. Rank held Alzamend Neuro as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.